When the biggest endocrinology conference in the world happens, professionals from around the world take notice! Boston was the hot spot the first week in June for ENDO 2024, welcoming over 7,000 endocrinologists from around the world to Boston in what turned out to literally be a meeting for the record books! In a 1993...
First Impressions: Talking with First-Time ENDO 2024 Attendees
Once again, Endocrine News chats with a group of members whose trip to Boston made quite an impression on them when they experienced their very first ENDO. We find out what they thought about their first experience at ENDO 2024, what surprised them the most, their favorite sessions, and why they would recommend it to...New International Guideline-Writing Partnership Debuts at ENDO 2024
While at ENDO 2024 in Boston, the Endocrine Society and European Society of Endocrinology together released the first in a series of guidelines co-authored by the societies. The “European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency” will better prepare endocrinologists to take the lead on a...In the Loop: Q&A with Endocrine Society Podcaster Chase Hendrickson, MD, MPH
When the Endocrine Society debuted the Endocrine Feedback Loop podcast back in 2020, it quickly took on a life of its own as host and creator Chase Hendrickson, MD, MPH, explains to Endocrine News. More than simply a new and improved journal club, the podcast seeks to educate, inform, and enlighten both listeners and the...
Two Medication Classes Reduced Cardiovascular and Liver Events in People with Type 2 Diabetes
GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data presented at ENDO 2024. Researchers reviewed Medicare data documented from 2013 to 2020 and a large U.S. health insurance database from 2013 to 2022. They performed...
Low Socioeconomic Status Raises Pregnant Women’s Risk of Exposure to Thyroid-Disrupting Chemicals
Exposure to some endocrine-disrupting chemicals (EDCs) that harm the thyroid gland has increased over the past 20 years among U.S. women of childbearing age and pregnant women, especially among those with lower social and economic status, according to a study presented at ENDO 2024. The researchers focused this study on women who may be particularly...
Type of Weight Loss Surgery Women Undergo Before Pregnancy May Influence Children’s Weight Gain
The type of weight loss surgery women undergo before becoming pregnant may affect how much weight their children gain in the first three years of life, according to a study presented at ENDO 2024. Researchers found children born to women who underwent sleeve gastrectomy before they became pregnant gain more weight per month on...
